Blood test to predict nerve damage from chemotherapy
Part of Brain & nervous system, Cancer, Pain clinical trials.
This study aims to find a blood test that can predict which patients will develop nerve pain or numbness (peripheral neuropathy) from certain chemotherapy drugs. You may be eligible if you are about to start treatment with paclitaxel, docetaxel, or oxaliplatin for at least 9 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are about to receive chemotherapy with one of these drugs: paclitaxel, docetaxel, or oxaliplatin, for at least 9 weeks.
- You do not already have nerve damage or chronic nerve pain.
- You do not have diabetes (type 1 or 2 for more than 10 years).
- You have not had other nerve-damaging cancer treatments before.
- You are not receiving immunotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain markers in your blood can predict nerve damage from paclitaxel chemotherapy. If you join, researchers will monitor your nerve health during treatment to better understand and possibly prevent side effects.
This study looks for small molecules in the blood that might predict nerve damage caused by certain chemotherapies. If you have colorectal or lung cancer and are starting a specific chemo plan, this trial could help researchers understand why some people get nerve problems and others don't.
This study looks at tiny particles in your blood to understand and potentially predict nerve damage caused by certain chemotherapy drugs. Researchers will monitor you before, during, and after your cancer treatment to see if these particles can help warn doctors about this common side effect.
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
This study looks at chemotherapy-related nerve damage (often felt as numbness, tingling, or pain) and why it happens and should matter. You may be eligible if you had a normal nerve check before chemotherapy started, or if your nerve symptoms are stable after finishing treatment.
This trial tests if wearing compression gloves and socks during chemotherapy can prevent nerve damage in hands and feet caused by taxane or oxaliplatin treatment. It may help patients avoid numbness, tingling, or pain.
Hear when a new Chemotherapy Induced Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.